S taphylococcus aureus is a major pathogen responsible for various infections in humans and is the most frequent cause of infective endocarditis in industrialized countries. 1 Prerequisite for the pathogenesis of infective endocarditis is infection of the endocardium.
S taphylococcus aureus is a major pathogen responsible for various infections in humans and is the most frequent cause of infective endocarditis in industrialized countries. 1 Prerequisite for the pathogenesis of infective endocarditis is infection of the endocardium. 2 Therefore, one of the first and essential steps is bacterial adhesion to the endothelium. In contrast to other pathogens causing infective endocarditis, S. aureus appears to be able to bind not only to damaged but also to intact endothelium. [3] [4] [5] Fibrinogen, fibronectin, and platelets, in combination with S aureus clumping factor and fibronectin-binding proteins, are involved in the pathogenesis of infective endocarditis. [6] [7] [8] In addition, wall teichoic acids of S aureus have been implicated in adhesion to the endothelial cell (EC) layer. 9 However, the molecular mechanisms of the very first adhesion steps of S aureus to the undamaged endothelium are still largely unknown.
Clinical Perspective on p 59
Recruitment of host cells to the endothelium is a crucial step during inflammation and coagulation. It has been shown previously that under shear von Willebrand factor is a potent binding partner for platelets and a key molecule for the extravasation of leukocytes during inflammation on intact endothelium. 10 VWF is a large multimeric glycoprotein that is produced mainly by ECs and stored in Weibel-Palade bodies. Acute activation of ECs is followed by a rapid release of VWF to the luminal side of ECs. 11 After secretion, VWF is elongated as a result of blood flow and forms ultralarge VWF (ULVWF) fibers on an intact endothelial layer. 12 In contrast to globular VWF, ULVWF under shear exposes the cryptic glycoprotein Ib▭ platelet binding site to which platelets bind with high affinity. 12 To maintain homeostasis, ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motifs 13) rapidly degrades ULVWF fibers stretched on high shear stress as present by passage through the microcirculation. 12 Lack or consumption of ADAMTS13 activity under pathophysiological conditions such as thrombotic thrombocytopenic purpura, sepsis, or other inflammatory diseases prohibits VWF cleavage and can lead to vessel occlusion resulting from thrombus formation. 13, 14 Because the release of VWF to the luminal side of ECs occurs without cell damage, we have tested whether VWF might function as a potential bridging molecule for the initial adherence of staphylococci to the endothelium. Indeed, previous studies have shown an interaction of VWF with S aureus using purified VWF or surface-immobilized recombinant VWF under low-shear conditions and indicate that staphylococcal protein A (SpA) might serve as a specific binding partner. 15, 16 This study has been designed to investigate the role of ULVWF fibers on S aureus adherence to an intact human endothelial layer under high-shear-stress conditions to which the heart valve endothelium is subjected. 17 Because current animal models for infective endocarditis depend on damaging the heart valves, 18 we established an artificial blood vessel. This microfluidic system mimics the pathophysiological conditions of endocarditis, reflecting flow rates of large arteries. 19 To verify the role of VWF for bacterial adhesion in vivo, we used a nontraumatic animal model.
Methods

Bacteria
The staphylococcal strains and derivatives used in this study are listed in the Table. Staphylococcal strains were cultivated as described in the online-only Data Supplement. After cultivation, bacteria were stained either with FITC (Sigma-Aldrich, Steinheim, Germany) or TRITC (Sigma-Aldrich, Steinheim, Germany) as previously described. 20 Optical densities of bacterial suspensions were adjusted to an OD 540 of 1 corresponding to 3×10 9 colony-forming units (CFU)/mL.
In Vitro Perfusion Assay of Human Umbilical Vein ECs
In vitro experiments with primary human umbilical vein ECs (HUVECs) were performed under flow conditions, applying an air pressure pump system. This device allows a unidirectional, continuous perfusion of an intact endothelium. The general pump technique of the IBIDI air pressure pump (IBIDI GmbH, Munich, Germany) system has been described previously. 24 In brief, HUVECs (1×10 7 cells per 1 cm 2 ) were seeded on gelatin-coated µ-Slide I 0.2 Luer (IBIDI GmbH) and cultivated under slight flow (1 dyne/cm 2 ) to confluence in EGM2 medium (Lonza, Basel, Switzerland). Fluorescence-labeled bacteria (3.6×10 7 CFU/mL) were resuspended in HEPES-buffered Ringer solution (10 mmol/L HEPES, 5 mmol/L glucose, 1 mmol/L calcium chloride, 1 mmol/L magnesium chloride, 5 mmol/L potassium chloride, 140 mmol/L sodium chloride), which was supplemented with 25% washed red blood cells to increase buffer viscosity and to approximate cellular constituents of physiological blood conditions. When indicated, platelets and serum were additionally added. Before the experiments, platelets were inhibited with prostaglandin and apyrase. 25 Serum either was heat-treated to inactivate ADAMTS13 or remained untreated. Measurements of the ADAMTS13 activity (ACTIFLUOR ADAMTS-13 Activity kit, American Diagnostica, Pfungstadt, Germany) revealed a lack of any activity in the heat-treated sample, whereas we found an activity of 744±168 ng/mL in untreated serum.
Histamine-activated (100 µmol/L) HUVECs were perfused with fluorescence-labeled live bacteria at corresponding flow rates for 20 minutes. When indicated, purified human fibrinogen (750 µg/mL; Sigma-Aldrich, Steinheim, Germany) or recombinant human ADAMTS13 (600 ng/mL) was added. Immunofluorescence staining of luminally secreted VWF was performed to analyze bacterial adherence to VWF on intact endothelium. Detailed protocols are available in the online-only Data Supplement.
In Vitro Perfusion Assay of Functionalized Surfaces
Functionalized surfaces coated either with human full-length recombinant wild-type VWF (rwtVWF) or VWF deletion mutants lacking the A1 domain (VWFdelA1), the A2 domain (VWFdelA2), or the A3 domain (VWFdelA3) were flushed with fluorescence-labeled S aureus SA113 (3.6×10 7 CFU/mL) for 4 minutes at 10 dynes/cm 2 . To analyze the platelet-binding properties of these deletion mutants, we perfused washed, inactivated, and Celltrace Calcein Red-Orange, AM-(Invitrogen, Darmstadt, Germany) stained platelets over the functionalized surfaces. Bacterial and platelet adherence was analyzed by fluorescence microscopy using a microscope with ×40 objective (Zeiss, Jena, Germany). Adhesion was quantified at 12 fields of view for each microfluidic channel. More details of the VWF mutants and the coating are provided in the online-only Data Supplement.
Intravital Fluorescence Microscopy of the Mouse Dorsal Skinfold Chamber
After tumor necrosis factor-α stimulation of the tissue of the dorsal skinfold chamber, either VWF knockout mice or wt mice were challenged with fluorescence-labeled live S aureus. Thirty minutes after injection, intravital fluorescence microscopy was performed as described previously. 26 Quantitative offline analysis of bacterial adherence (given as clusters per 1 mm 2 of endothelial surface) in postcapillary and collecting venules was performed as described previously. 26 Bacterial adherence was analyzed in postcapillary and collecting venules. Detailed protocols are available in the online-only Data Supplement.
Statistical Analysis
In vitro perfusion assays with HUVECs were based on several independent batches of ECs; thus, VWF release and bacterial adhesion varied considerably between the experiments. Therefore, we normalized the result of the overall bacterial adhesion of each single experiment to 100%. 
Results
Luminally Released VWF Mediates S aureus Adhesion to Intact Endothelium In Vitro
To analyze the impact of luminally released VWF on S aureus adhesion to confluent endothelium, we flushed histamineactivated HUVECs with suspensions of 2 different S aureus strains (Cowan I and SA133) at a shear stress of 10 dynes/ cm 2 . In agreement with previous publications, formation of ULVWF fibers on the intact endothelium was shear flow dependent ( Figure 1A) . 12, 27 Adherence of individual S aureus cells or small bacterial clusters to an intact layer of ECs was almost exclusively mediated by ULVWF fibers ( Figure 1A and 1B and Figure IA and IB in the online-only Data Supplement). The highly dynamic process of the interaction between S aureus with ULVWF fibers under high-shear conditions is illustrated in a live image ( Figure II in the online-only Data Supplement) and by real-time movies showing the collapse and re-elongation of the ULVWF under stop-flow conditions and the waving of the fiber under continuous-flow (Movies 1 and 2 in the online-only Data Supplement). Entrapment of S aureus by ULVWF fibers was also confirmed by high-resolution atomic force microscopy ( Figure III in the online-only Data Supplement). Quantification of the fluorescence images proved that a total of 73±29 cocci per 1 mm 2 of S aureus SA113 (n=11) and 49±28 cocci per 1 mm 2 of S aureus Cowan I (n=7) adhered to the intact endothelium. In both cases, ≈95% of S aureus colocalized with ULVWF, whereas VWF-independent adhesion was rare (96±2% of S aureus SA113 and 95±6% of S aureus Cowan I VWF mediated versus 4±2% of S aureus SA113 and 5±6% of S aureus Cowan I VWF independent, respectively [mean±SD]; Figure 1C ).
Our data indicate that endothelium-derived ULVWF functions as a dominant binding partner for S aureus. To further 
Fibrinogen Has No Effect on Initial VWF-Mediated S aureus Binding to Endothelium
Because recent studies showed that fibrinogen acts as a bridging molecule for staphylococcal adhesion to the endothelium, 7, 28 we analyzed the impact of fibrinogen on S aureus adhesion under high shear flow. Although fibrinogen induced bacterial cluster formation as expected, 28 neither VWF-mediated nor VWFindependent S aureus adherence was affected (VWF-mediated, 95±6% without fibrinogen [n=7] versus 87±11% with fibrinogen [n=3]; VWF-independent, 5±6% without fibrinogen versus 13±11% with fibrinogen [mean±SD]; Figure 3A ). Figure 3B shows large adherent S aureus clusters formed in the presence of fibrinogen that were entrapped by ULVWF.
VWF-Mediated S aureus Binding via Protein A Is Shear Flow Dependent
To analyze the impact of SpA, a surface-associated molecule, on the bacterial interaction with VWF, we compared an isogenic SpA-deficient mutant with its parental wt strain (S aureus Cowan I). Within a paired experiment, both bacterial strains were perfused over activated HUVECs with a shear stress of 2.5 dynes/cm 2 (n=3) or 10 dynes/cm 2 (n=5). Adhesion of the SpA mutant to VWF was significantly decreased at low shear flow (2.5 dynes/cm 2 ) compared with the wt strain (54±3% S aureus SpA adhesion versus 93±3% S aureus Cowan I adhesion [mean±SD]; Figure 4A ). However, at high-shear-flow conditions (10 dynes/cm 2 ), S aureus SpA binding to VWF (116±9% [mean±SD]) was even significantly increased compared with the wt adhesion (95±6% [mean±SD]; Figure 4B ). Figure 4C shows a representative immunofluorescence image of S aureus SpA binding to ULVWF fibers under high shear flow.
Bacterial Binding to VWF Under High Shear Stress Is Multifactorial, Involving Diverse S aureus Virulence Factors
Because protein A does not account for S aureus binding to luminally released VWF at high shear flow, we investigated the influence of other bacterial adhesion molecules. Therefore, suspensions with different bacterial mutants were perfused over activated HUVEC layers with a shear stress of 10 dynes/ cm 2 . The apathogenic S carnosus, which does not possess major S aureus surface proteins, 8, 23 showed a low VWF binding capacity (17±3% [mean±SD]; n=4) compared with S aureus SA113 (96±2% [mean±SD]; n=11; Figure 5 ). The S aureus mutants srtA and tagO are deficient in LPXTG-anchored surface proteins and wall teichoic acid, respectively. 21, 22 Binding of both mutants to VWF was significantly reduced compared with S aureus SA113 wt (S aureus srtA, 32±1% [n=4]; S aureus tagO, 44±2% [n=5; mean±SD]; Figure 5 ).
The A1 and A3 Domains of VWF Mediate Bacterial Adherence
VWF has binding sites for various molecules such as platelet glycoprotein Ib, collagens, or glycosaminoglycans like heparin. These functional binding sites are located mainly within the A-type domains consisting of A1, A2, and A3. [29] [30] [31] The presence of unfractionated heparin reduced the binding of S aureus to VWF, suggesting the involvement of the VWF A1 domain (VWF mediated, 95±6% adhesion without [n=7] versus 16±2% adhesion with [n=3] heparin [mean±SD]; Figure 6A ). However, heparin is not a specific blocker of the A1 domain but is able to influence other binding pathways of S aureus. 32 Analysis of the VWF-independent bacterial adherence revealed a slightly reduced binding on heparin treatment (VWF independent, 5±6% adhesion without [n=7] versus 3±2% adhesion with [n=3] heparin [mean±SD]; Figure 6A ), pointing to an interference of heparin with bacteria trapped by the endothelial glycocalyx. 32 To further specify the contribution of the A-type domains for S aureus binding, we synthesized genetically modified recombinant VWF molecules lacking the A1 (VWFdelA1), A2 (VWFdelA2), or A3 (VWFdelA3) domain and perfused S aureus over surfaces functionalized with this recombinant VWF. S aureus SA113 (n=10) adhesion to VWFdelA1 and VWFdelA3 was significantly decreased compared with the adhesion to rwt-VWF ( Figure 6B ). Adhesion to VWFdelA2 was only slightly reduced ( Figure 6B ). Next, we perfused VWF-functionalized surfaces with S aureus tagO (n=5) and S aureus srtA (n=5). However, this gave no further insight into the molecular mechanisms responsible for the interaction between VWF and S aureus because the adherence patterns were very similar in all mutants ( Figure 6B ).
To prove the functionality of our VWF-mutants, we measured their capacity to bind platelets. As expected, we found a reduced platelet binding only toward VWFdelA1, whereas binding to VWFdelA2 and VWFdelA3 was not affected (n=5; Figure 6C ).
31
Bacterial Binding Is Affected by Platelets and ADAMTS13
Serum contains several proteins like immunoglobulins or plasmatic VWF that could interact with S aureus, whereas platelets bind with high affinity via glycoprotein Ibα to the A1 domain exposed by stretched VWF under shear. An increased competition of the acting binding partners for specific VWF binding might be the consequence. Therefore, we further upgraded our in vitro flow device with inactivated platelets and serum lacking ADAMTS13 activity (Figure 7 ). However, we found an ≈2-fold increased bacterial adherence to the endothelium and an even more dominant role of ULVWF (n=5; Figure 7A ). Immunofluorescence staining revealed that ULVWF fibers appear to be thicker and more robust in the presence of serum and platelets, implicating potentially more binding sites for S aureus ( Figure 7B ), as hypothesized previously. 33 On systemic inflammation, ADAMTS13 is consumed by overwhelming amounts of VWF released into the blood, 13 suggesting also a reduced concentration of ADAMTS13 in the course of endocarditis. In addition, it has been proposed that interleukin 6, which was found to be elevated in the blood of endocarditis patients, 34 could block ADAMTS13 activity. To understand the role of ADAMTS13 for the ULVWF-mediated adhesion of S aureus, we analyzed bacterial attachment in the presence of platelets and inactivated serum supplemented with different amounts of recombinant ADAMTS13 (n=4) or serum with a physiological ADAMTS13 activity (n=4). Figure 7C shows an inverted dose dependency between ADAMTS13 activity and VWF-mediated S aureus adherence.
Although 4-fold less bacteria attached to the endothelium in the presence of 100 ng/mL ADAMTS13 and 8-fold less bacteria in the presence of 200 ng/mL ADAMTS13, we could still detect VWF-mediated adhesion even at physiological levels of ADAMTS13 (744±168 ng/mL). Quantification of the ULVWF fiber length proves that, with increasing concentrations of ADAMTS13, the ratio of large fibers to small fibers decreases. However, functional ULVWF fibers were still formed in the presence of high levels of ADAMTS13 ( Figure 7D ).
VWF Is Required for Bacterial Adherence In Vivo
To obtain further evidence for the biological relevance of the S aureus-VWF interaction on undamaged endothelium, we performed in vivo experiments applying the dorsal skinfold chamber model. Bacterial binding in the microcirculation was analyzed by intravital fluorescence microscopy. 26 Release of VWF from the endothelium was induced by tumor necrosis factor-α topically applied to the investigated skin area 30 minutes before the experiment. Fiber formation within the lumen of vessels was controlled by immunofluorescence staining prepared on tissue sections ( Figure IV in the online-only Data Supplement). In total, we analyzed 160 vessels of 5 VWF knock-out mice (n=5) and 6 wt mice (n=6). After challenging the mice with bacteria, we found a markedly reduced bacterial adhesion in Figure 8 ). We found a significant difference in bacterial adhesion in the collecting venules according to the unpaired Student t test. Additionally, significance was confirmed with the nonparametric MannWhitney U test.
Discussion
S aureus is one of the main pathogens causing endocarditis. Initial adhesion to the endothelium is a crucial step for pathogenesis of this intravascular disease. Once bound to the vessel wall, S aureus is able to overcome the EC barrier and to spread to the surrounding tissue, leading to the establishment of infection.
Most of the previously performed studies focused on bacterial adhesion at sites of vascular injury. 7, 9 However, S aureus is also able to infect physically undamaged endothelium. [2] [3] [4] The molecular mechanisms of initial S aureus adherence to intact endothelium are mostly unknown, although fibronectin and fibrinogen are required as bridging molecules. 8, 28 In contrast to those studies, we aimed to investigate bacterial adherence to the intact endothelium during acute inflammatory conditions under distinct shear-flow conditions. Thus, we have established and adapted a microfluidic system to study activated ECs under arterial shear-flow conditions.
In the present study, we demonstrate that luminally released ULVWF acted as a predominant adhesive factor for S aureus, mediating the binding of the bacterium to an intact EC layer under high-shear-flow conditions (Figures 1 and 2 ). Only <5% of the attached bacteria interact in a VWF-independent manner that might be attributable to EC surface associated fibronectin or surface-exposed glycosaminoglycans (Figures 1 and  6A) . 8, 20, 32 Previous studies demonstrated plasmatic fibrinogen as a potent binding partner of S aureus that triggers the formation of bacterial clusters and bacterial adhesion to the endothelium.
7,28 Therefore, we also investigated whether the presence of fibrinogen could affect the VWF-mediated interaction between the intact endothelium and S aureus. Although fibrinogen led to the formation of bacterial clusters, we found that neither the VWF-mediated nor the VWF-independent amount of colony-forming units of endothelium-bound bacteria was increased in the presence of fibrinogen. Accordingly, our data suggest that binding of S aureus to the endothelium is initiated by VWF and that VWF is able to not only sequester single bacteria but also entrap large bacterial clusters (Figure 3) .
One potential binding partner of VWF expressed by S aureus is protein A. In this context, Hartleib et al 15 showed a specific interaction of SpA with VWF under low shear flow. Therefore, we compared the VWF binding capacities of an isogenic S aureus wt/SpA strain pair within our experimental setting. In line with the previous results, we observed an SpA dependency at low-shear-flow conditions. However, at highshear-flow conditions, we measured an SpA-independent S aureus adhesion (Figure 4) . Notably, these findings of a shear flow dependency are supported by results obtained by O'Seaghdha and coworkers 35 showing that Lactococcus lactis derivatives expressing the SpA bind to recombinant human VWF under low shear rates but not under high shear rates. To reveal the potential bacterial binding partner for VWF under high-shear-flow conditions, we first determined the interaction between VWF and S aureus srtA, which lacks all cell wall-anchored surface proteins. 22 Adhesion of S aureus srtA to ULVWF was higher than the adhesion of the nonpathogenic S carnosus, which lacks all relevant surface-associated adhesins, 23 suggesting the involvement of additional bacterial surface molecules for VWF adhesion ( Figure 5) . Therefore, we analyzed the role of wall teichoic acids, which are highly abundant, surface-exposed glycopolymers incorporated into bacterial cell walls. Our data indeed suggest the attendance of wall teichoic acids because we found a significantly reduced adhesion of the S aureus tagO mutant compared with S aureus wt adhesion ( Figure 5 ). Interaction of host lectins such as galectins and wall teichoic acid has already been debated and is the subject of ongoing investigations in our laboratories. 22 Interestingly, galectin 1 and 3 are both expressed by human ECs and released in complex with VWF. 36 The A1 domain of luminally exposed, stretched VWF provides binding sites not only for the platelet receptor glycoprotein Ib but also for collagen and heparin. 31 The A3 domain contains binding sites for collagen type I and III, 29 whereas the A2 domain has no adhesive properties but contains the cleavage site for ADAMTS13. 37 Our experiments indicate that S aureus is immobilized mainly on stretched VWF fibers exposing the A-type domains. Blocking of the A1 domain with heparin revealed a 6-fold reduction of the VWF-mediated adhesion of S aureus to the endothelium ( Figure 6A ). In agreement with our data, Li et al 38 previously showed a heparin-dependent reduction of bacterial binding to VWF. We confirmed the impact of the A1 domain by a reduced adherence of S aureus to functionalized surfaces coated with recombinant VWF lacking the A1 domain. Interestingly, bacterial adhesion to surfaces coated with recombinant VWF lacking the A3 domain was also strongly diminished, indicating a significant impact of the A3 or collagen binding domain of VWF on bacterial binding ( Figure 6B ). To the best of our knowledge, there are to date no confirmed S aureus surface molecules with specific sequence-based homologies with collagen types I and III. However, it might be possible that quaternary structures create de novo binding sites that are based on the structural configuration rather than on direct sequence similarity.
The shear-activated VWF A2 domain provides a cleavage site for the plasma protease ADAMTS13, which efficiently cleaves ULVWF fibers under physiological conditions. 12, 37 Therefore, VWF fibers are postulated to exist only on reduced ADAMTS13 activity, as known in patients suffering from thrombotic thrombocytopenic purpura.
14 However, the amount and activity of ADAMTS13 were also found to be reduced during systemic inflammation such as sepsis, leading to the persistent formation of ULVWF fibers. 13, 39 These studies showed that ADAMTS13 activity correlates inversely with patient outcome. 40 Secondary deficiency of ADAMTS13 is related to the consumption of ADAMTS13 caused by an increased amount of VWF in the circulation or by its inhibition by inflammatory cytokines. 41 To the best of our knowledge, the existence or absence of ADAMTS13 in patients suffering from endocarditis has not yet been investigated. Therefore, we performed experiments with different concentrations of ADAMTS13 to predict its role in the onset of ULVWF-mediated binding of S aureus. Although the amount and length of ULVWF fibers exposed on the endothelial surface were drastically diminished in the presence of physiological amounts of ADAMTS13 (744±168 ng/mL), we still found bacteria tethered by VWF. Assuming a consumption or inhibition of ADAMTS13 in affected patients, our experiments predict an even more significant contribution of ULVWF to bacterial binding. In agreement with our in vitro data, we were also able to detect luminally released VWF fibers in the vessels of mice treated with tumor necrosis factor-α, suggesting the formation of ULVWF in vivo.
To further prove the pathological relevance of our results, we studied the interaction between human endothelium and S aureus not only in the presence of red blood cells but together with platelets and serum. Although we expect a decoration of S aureus with IgG or soluble VWF on the one hand and the occupation of the A1 domain by platelets on the other hand, we found an even increased contribution of ULVWF to bacterial binding. Interestingly, we also found that ULVWF strings decorated with platelets are thicker and more robust than ULVWF without platelets, suggesting an improved docking of bacteria. To investigate the pure effect of ULVWF for S aureus adherence, we performed our flow experiments with inactivated platelets, preventing the exposure of active glycoprotein IIb/IIIa, a well-known binding partner for S aureus.
The major drawback of current animal models for infective endocarditis is the artificial destruction of the endothelium prior to bacterial inoculation. 18 We aimed to circumvent this strategy by applying our recently described in vivo model of the dorsal skinfold chamber. 26 To measure the role of VWF for bacterial trapping, we compared wt mice with mice deficient in VWF. It is worth noting that the lack of VWF leads also to a lack of Weibel-Palade bodies, accompanied by a disturbed processing of various endothelium-derived factors such as P-selectin. 42 Although P-selectin is a potent binding partner for leukocytes and potentially responsible for the anchorage of the ULVWF to the EC surface, 43 it has recently been excluded as adhesion molecule for S aureus. 44 Applying our experimental in vivo setting together with intravital fluorescence microscopy, we showed a significant reduction of bacterial adhesion in VWF knockout mice (Figure 8 ). This further underlines the physiological relevance of VWF-mediated attachment of S aureus to intact microvasculature.
Conclusions
We could show that binding of S aureus to the intact EC layer is mediated predominantly by luminally secreted ULVWF fibers involving the A1 and A3 domains. Bacterial adhesion to VWF is resistant to even high-shear-flow conditions because shear flow-activated ULVWF fibers support S aureus binding. Our data shed light on the initial early pathogenetic steps of S aureus endocarditis in patients with an apparently intact endothelium. From our findings, one can speculate that therapeutic intervention with recombinant ADAMTS13, as is discussed for patients suffering from thrombotic thrombocytopenic purpura, 45 or heparin could be a novel approach as adjunctive therapy besides the current antibiotic-based therapy for infective endocarditis. 
CLINICAL PERSPECTIVE
In the past, there was a major shift in both the patient population and the microbial spectrum of infective endocarditis. Staphylococci, especially Staphylococcus aureus, are now the leading cause in industrialized countries. However, in >50% of patients, no previously known heart disease considered a classic risk factor is identified, suggesting alternative, unknown mechanisms for establishing disease. Von Willebrand Factor is luminally secreted on proinflammatory stimulation of endothelial cells and under high shear stress temporarily forms large fibers, entrapping platelets. We hypothesized that S aureus also might be sequestered via this mechanism because it binds to von Willebrand Factor via protein A and to platelets via various surface proteins. In a microfluidic chamber, S aureus adhered in a platelet-and protein A-independent manner to activated endothelial cells. Adherence was ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motifs 13) susceptible. Wall teichoic acid substantially mediated adherence under high shear stress. Platelets and serum substantially enhanced binding. Using recombinant von Willebrand Factor constructs, we were able to map the involved binding domains. Furthermore, we showed in an intravital microscopy model that circulating S aureus also binds to von Willebrand Factor fibers on activated endothelial cells in vivo. To the best of our knowledge, this is the first study showing that S aureus binds to morphologically intact but activated endothelial cells under high-shear-stress conditions that are thought to exist at the predilection sites for infective endocarditis. This finding sheds light on the initial steps during the pathogenesis of endocarditis and might provide the basis for novel strategies for prevention and treatment by targeting von Willebrand Factor fibrils. 
Immunofluorescence staining of VWF
In vitro perfusion of functionalized surfaces
Human full length recombinant wild type VWF (rwtVWF) and VWF deletion mutants lacking the A1 (VWFdelA1: deletion of amino acid residues E1260-G1479), A2 (VWFdelA2: deletion of amino acid residues N1493-E1673) or the A3 domain (VWFdelA3: deletion of amino acid residues G1672-G1874) were expressed in 293-EBNA cells (Invitrogen, Darmstadt, Germany) as previously described. 2 Perfusion experiments with functionalized surfaces were performed with the BioFlux 200 flow system (Fluxion, San Francisco, USA) as previously described. 3 In brief, channels of 24 Well BioFlux plates were coated either with rwtVWF, VWFdelA1, VWFdelA2 or VWFdelA3 applying a solution of 100 µg/ml for 2h at 37°C. To remove excess VWF, channels were flushed with HEPES-buffered ringer solution Laboratory, Maine, USA) with a body weight of 22-25 g were used for the study. Dorsal skinfold chambers were prepared in mice as described previously in detail. 5 After the surgery, the animals were allowed to recover from anesthesia and surgery for at least 48 h before the microcirculatory analyses. For intravital fluorescence microscopy, the animals were anesthetized (75mg/kg body weight ketamine introperitoneal injection (i.p.) (Pharmacia GmbH, Erlangen, Germany) and 15mg/kg body weight xylazin i.p. (Bayer, Leverkusen, Germany)) and a fine polyethylene catheter (PE10, 0.28 mm internal diameter) was inserted into the A. carotis for application of bacteria and fluorescent dyes. For endothelial cell stimulation, the tissue of the dorsal skinfold chamber was exposed to TNF-α (topical application of 2000 U dissolved in 100 µL PBS) (Roche, Mannheim, Germany) for 30 min.
Subsequently, the mice were attached to the microscopic stage. After analysis of the
